Anne Fleur Kortekaas-Rijlaarsdam

171 REFERENCES Volpe, R., DuPaul, G., DiPerna, J. C., Jitendra, A. K., Lutz, J. G., Tresco, K., & Vile Junod, R. (2006). Attention deficit hyperactivity disorder and scholastic achievement: A model of mediation via academic enablers. School Psychology Review , 35 (1), 47–61. Wechsler, D. (2005). The Wechsler Intelligence Scale for Children - III - Revised (III). San Antonio, TX: The Psychological Corporation. Wellek, S., & Blettner, M. (2012). Vom richtigen Umgang mit dem Crossover-Design in klinischen Studien: Teil 18 der Serie zur Bewertung wissenschaftlicher Publikationen. Deutsches Arzteblatt International , 109 (15), 276–281. https://doi.org/10.3238/arztebl.2012.0276 Widaman, K. F., Geary, D. C., Cormier, P., & Little, T. D. (1989). A componential model for mental addition. Journal of Experimental Psychology. Learning, Memory, and Cognition , 15 (5), 898–919. https://doi. org/10.1037/0278-7393.15.5.898 Wigal, S. B., Childress, A., Berry, S. A., Belden, H., Walters, F., Chappell, P., … Palumbo, D. (2017). Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention- Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology , 27 (8), cap.2016.0177. https://doi.org/10.1089/cap.2016.0177 Wigal, S. B., Greenhill, L. L., Nordbrock, E., Connor, D. F., Kollins, S. H., Adjei, A., …Kupper, R. J. (2014). A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/ hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology , 24 (10), 562–569. Wigal, S. B., Gupta, S., Guinta, D., & Swanson, J. M. (1998). Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacology Bulletin , 34 (1), 47–53. Wigal, S. B., Gupta, S., Heverin, E., & Starr, H. L. (2011). Pharmacokinetics and therapeutic effect of OROS(registered trademark) methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology , 21 (3), 255–263. Wigal, S. B., Wigal, T., Schuck, S., Brams, M., Williamson, D., Armstrong, R. B., & Starr, H. L. (2011). Academic, behavioral, and cognitive effects of OROS(registered trademark) methylphenidate on older children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology , 21 (2), 121–131. Wigal, S. B., Wigal, T., Schuck, S., Brams, M., Williamson, D., Armstrong, R. B., & Starr, H. L. (2011). Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology , 21 (2), 121–131. https://doi.org/10.1089/cap.2010.0047 Wigal, S., Swanson, J. M., Feifel, D., Sangal, R. B., Elia, J., Casat, C. D., …Conners, C. K. (2004). A double- blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry , 43 (11), 1406–1414. Wigfield, A., & Eccles, J. S. (2000). Expectancy-value theory of achievement motivation. Contemporary Educational Psychology , 25 , 68–81. Wilens, T. E., Boellner, S. W., Lopez, F. A., Turnbow, J. M., Wigal, S. B., Childress, A. C., … Manos, M. J. (2008). Varying the wear time of the methylphenidate transdermal system in children with attention- deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry , 47 (6), 700–708. Wilkison, P. C., Kircher, J. C., McMahon, W. M., & Sloane, H. N. (1995). Effects of methylphenidate on reward strength in boys with attention- deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry , 34 (7), 897–901. Willcutt, E., Betjemann, R., Pennington, B., Olson, R., Defries, J., & Wadsworth, S. (2007). Longitudinal Study of Reading Disability and Attention‐Deficit/Hyperactivity Disorder: Implications for Education. Mind, Brain, and Education , 1 (4), 181–192. Willcutt, E. G. (2012). The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta- Analytic Review. Neurotherapeutics , 9 , 490–499. https://doi.org/10.1007/s13311-012-0135-8 Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V, & Pennington, B. F. (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry , 57 (11), 1336–1346. https://doi.org/10.1016/j.biopsych.2005.02.006